Here’s what you should know.
1. A study, presented at the 2nd World Arthroplasty Congress in Rome, Italy, April 19 to April 21, found patients had a significant improvement in knee function at six months after using the Attune knee.
2. DePuy Synthes then summarized a series of studies in a report it presented. In each of the five studies, Attune knee patients had a shorter length of stay than patients receiving comparable implants.
3. DePuy Synthes EMEA Joint Reconstruction Vice President Torbjorn Skold said, “I’m delighted that this data demonstrated that study patients receiving the Attune knee experienced positive outcomes related to the rate of return of functional outcomes and reduced length of stay, allowing these patients to get back to a positive quality of life.”
More articles on orthopedics:
Carl King takes the helm of NueHealth Holdings: 6 things to know
Dr. Julian Cameron leverages Less Exposure Surgery tech at Florida ASC — 4 highlights
Coding tip of the day: Avoid coding burnout with simple strategies
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.